Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

November-December 2016; Volume 13,Issue 6
  • Open Access
    Mechanisms and Targets Involved in Dissemination of Ovarian Cancer
    ULRICH H. WEIDLE, FABIAN BIRZELE, GWENDLYN KOLLMORGEN and RÜDIGER RUEGER
    Cancer Genomics & Proteomics November 2016, 13 (6) 407-423;
  • Open Access
    Clinical and Therapeutic Implications of Follistatin in Solid Tumours
    LEI SHI, JEYNA RESAUL, SIONED OWEN, LIN YE and WEN G. JIANG
    Cancer Genomics & Proteomics November 2016, 13 (6) 425-435;
  • Open Access
    Differential Expression of Ccn4 and Other Genes Between Metastatic and Non-metastatic EL4 Mouse Lymphoma Cells
    MANPREET S. CHAHAL, H. TERESA KU, ZHIHONG ZHANG, CHRISTIAN M. LEGASPI, ANGELA LUO, MANDI M. HOPKINS and KATHRYN E. MEIER
    Cancer Genomics & Proteomics November 2016, 13 (6) 437-442;
  • Open Access
    Characterization of Heparan Sulfate Proteoglycan-positive Recycling Endosomes Isolated from Glioma Cells
    KATARZYNA A. PODYMA-INOUE, TAKUYA MORIWAKI, ANUPAMA R. RAJAPAKSHE, KAZUE TERASAWA and MIKI HARA-YOKOYAMA
    Cancer Genomics & Proteomics November 2016, 13 (6) 443-452;
  • Open Access
    In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue
    ALI AZIMI, KIMBERLEY L. KAUFMAN, MARINA ALI, STEVEN KOSSARD and PABLO FERNANDEZ-PENAS
    Cancer Genomics & Proteomics November 2016, 13 (6) 453-465;
  • Open Access
    A Comparative Study of the Molecular Characteristics of Familial Gliomas and Other Cancers
    JIE LU, MARK G. BURNETT and MAX SHPAK
    Cancer Genomics & Proteomics November 2016, 13 (6) 467-474;
  • Open Access
    Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR Mutation
    KAZUTOSHI ISOBE, ATSUSHI KAKIMOTO, TETSUO MIKAMI, KYOHEI KABURAKI, HIROSHI KOBAYASHI, TAKAHIRO YOSHIZAWA, TAKASHI MAKINO, HAJIME OTSUKA, GO SANO, KEISHI SUGINO, SUSUMU SAKAMOTO, YUJIRO TAKAI, NAOBUMI TOCHIGI, AKIRA IYODA and SAKAE HOMMA
    Cancer Genomics & Proteomics November 2016, 13 (6) 475-482;
  • Open Access
    Association Between Type-specific HPV Infections and hTERT DNA Methylation in Patients with Invasive Cervical Cancer
    MÓNICA MOLANO, PABLO MORENO-ACOSTA, NICOLÁS MORALES, MARCELA BURGOS, LINA BUITRAGO, OSCAR GAMBOA, RAYNER ALVAREZ, SUZANNE M. GARLAND, SEPEHR N. TABRIZI, RENSKE D.M. STEENBERGEN and JUAN CARLOS MEJÍA
    Cancer Genomics & Proteomics November 2016, 13 (6) 483-491;
  • Open Access
    Introduction of ID2 Enhances Invasiveness in ID2-null Oral Squamous Cell Carcinoma Cells via the SNAIL Axis
    YU KAMATA, TOMOKI SUMIDA, YOSUKE KOBAYASHI, AKIKO ISHIKAWA, WATARU KUMAMARU and YOSHIHIDE MORI
    Cancer Genomics & Proteomics November 2016, 13 (6) 493-497;
  • Open Access
    Archetype and Rearranged Non-coding Control Regions in Urothelial Bladder Carcinoma of Immunocompetent Individuals
    ELENA ANZIVINO, MARIA ANTONELLA ZINGAROPOLI, MARCO IANNETTA, VALERIA ANTONIETTA PIETROPAOLO, ALESSANDRA OLIVA, FRANCESCO IORI, ANTONIO CIARDI, DONATELLA MARIA RODIO, FRANCESCA ANTONINI, CESARE GIOVANNI FEDELE, ALESSANDRA D'ABRAMO, CLAUDIO MARIA MASTROIANNI, VINCENZO VULLO and MARIA ROSA CIARDI
    Cancer Genomics & Proteomics November 2016, 13 (6) 499-509;
  • Open Access
    Platelet Derived Growth Factor BB: A “Must-have” Therapeutic Target “Redivivus” in Ovarian Cancer
    ANCA MARIA CIMPEAN, IONUT MARCEL COBEC, RALUCA AMALIA CEAUȘU, ROXANA POPESCU, ANCA TUDOR and MARIUS RAICA
    Cancer Genomics & Proteomics November 2016, 13 (6) 511-517;
  • Open Access
    Index
    Cancer Genomics & Proteomics November 2016, 13 (6) 519-537;
Back to top
PreviousNext

In this issue

Cancer Genomics & Proteomics
Vol. 13, Issue 6
November-December 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2025 Cancer Genomics & Proteomics

Powered by HighWire